All‐Trans Retinoic Acid Promotes a Tumor Suppressive OTUD6B‐β‐TrCP‐SNAIL Axis in Esophageal Squamous Cell Carcinoma and Enhances Immunotherapy

β‐TrCP is an E3 ubiquitin ligase that plays important roles in multiple human cancers including esophageal squamous cell carcinoma (ESCC). Analysis of ESCC patient samples reveal that only protein level but not transcript level of β‐TrCP associated with patient prognosis, suggesting regulators of β‐TrCP protein stability play an essential role in ESCC progression and may be novel targets to develop ESCC therapies. Although β‐TrCP stability is known to be mediated by the ubiquitin‐proteasome system, it is unclear which enzymes play a major role to determine β‐TrCP stability in the context of ESCC. In this study, OTUD6B is identified as a potent deubiquitinase of β‐TrCP that suppress ESCC progression through the OTUD6B‐β‐TrCP‐SNAIL axis. Low OTUD6B expression is associated with a poor prognosis of ESCC patients. Importantly, all‐trans retinoic acid (ATRA) is found to promote OTUD6B translation and thus suppress ESCC tumor growth and enhance the response of ESCC tumors to anti‐PD‐1 immunotherapies. These findings demonstrate that OTUD6B is a crucial deubiquitinase of β‐TrCP in ESCC and suggest combination of ATRA and anti‐PD‐1 immune checkpoint inhibitor may benefit a cohort of ESCC patients.

[1]  Eleni G. Christodoulou,et al.  A novel network pharmacology approach for leukaemia differentiation therapy using Mogrify® , 2022, Oncogene.

[2]  O. McDonald,et al.  APE1 redox function is required for activation of Yes-associated protein 1 under reflux conditions in Barrett’s-associated esophageal adenocarcinomas , 2022, Journal of Experimental & Clinical Cancer Research.

[3]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[4]  Zhiyun Xu,et al.  All-Trans Retinoic Acid Prevented Vein Grafts Stenosis by Inhibiting Rb-E2F Mediated Cell Cycle Progression and KLF5-RARα Interaction in Human Vein Smooth Muscle Cells , 2020, Cardiovascular Drugs and Therapy.

[5]  Yongchao Zhao,et al.  The characteristics and roles of β‐TrCP1/2 in carcinogenesis , 2020, The FEBS journal.

[6]  L. Fu,et al.  A new mouse esophageal cancer cell line (mEC25)‐derived pre‐clinical syngeneic tumor model for immunotherapy , 2020, Cancer communications.

[7]  Mengzhong Liu,et al.  TRIB3 confers radiotherapy resistance in esophageal squamous cell carcinoma by stabilizing TAZ , 2020, Oncogene.

[8]  Lingqiang Zhang,et al.  Deubiquitylase OTUD6B Governs pVHL Stability in an Enzyme‐Independent Manner and Suppresses Hepatocellular Carcinoma Metastasis , 2020, Advanced science.

[9]  Yi Zhang,et al.  F-box proteins and cancer: an update from functional and regulatory mechanism to therapeutic clinical prospects , 2020, Theranostics.

[10]  Yinghua Zhu,et al.  Targeting Pin1 by All-Trans Retinoic Acid (ATRA) Overcomes Tamoxifen Resistance in Breast Cancer via Multifactorial Mechanisms , 2019, Front. Cell Dev. Biol..

[11]  L. Di Marcotullio,et al.  ERAP1 promotes Hedgehog-dependent tumorigenesis by controlling USP47-mediated degradation of βTrCP , 2019, Nature Communications.

[12]  In-geun Ryoo,et al.  High NRF2 level mediates cancer stem cell-like properties of aldehyde dehydrogenase (ALDH)-high ovarian cancer cells: inhibitory role of all-trans retinoic acid in ALDH/NRF2 signaling , 2018, Cell Death & Disease.

[13]  H. Seo,et al.  Arsenic targets Pin1 and cooperates with retinoic acid to inhibit cancer-driving pathways and tumor-initiating cells , 2018, Nature Communications.

[14]  Guoan Chen,et al.  The β-TrCP-FBXW2-SKP2 axis regulates lung cancer cell growth with FBXW2 acting as a tumour suppressor , 2017, Nature Communications.

[15]  X. Liu,et al.  Snail1-dependent p53 repression regulates expansion and activity of tumour-initiating cells in breast cancer , 2016, Nature Cell Biology.

[16]  M. Amagai,et al.  Nivolumab for advanced melanoma: pretreatment prognostic factors and early outcome markers during therapy , 2016, Oncotarget.

[17]  Jun Yao,et al.  Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity , 2016, Nature Communications.

[18]  Osamu Kikuchi,et al.  Recent Advances From Basic and Clinical Studies of Esophageal Squamous Cell Carcinoma. , 2015, Gastroenterology.

[19]  J. Ruppert,et al.  SOX9 inhibits &bgr;-TrCP-mediated protein degradation to promote nuclear GLI1 expression and cancer stem cell properties , 2015, Journal of Cell Science.

[20]  C. Mathers,et al.  Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 , 2015, International journal of cancer.

[21]  Zhiwei Wang,et al.  Roles of F-box proteins in cancer , 2014, Nature Reviews Cancer.

[22]  A. Chinnaiyan,et al.  KRAS protein stability is regulated through SMURF2: UBCH5 complex-mediated β-TrCP1 degradation. , 2014, Neoplasia.

[23]  G. Berx,et al.  Epidermal Snail expression drives skin cancer initiation and progression through enhanced cytoprotection, epidermal stem/progenitor cell expansion and enhanced metastatic potential , 2013, Cell Death and Differentiation.

[24]  P. R. Elliott,et al.  OTU Deubiquitinases Reveal Mechanisms of Linkage Specificity and Enable Ubiquitin Chain Restriction Analysis , 2013, Cell.

[25]  S. Kulp,et al.  Targeting the Oncogenic E3 Ligase Skp2 in Prostate and Breast Cancer Cells with a Novel Energy Restriction-Mimetic Agent , 2012, PloS one.

[26]  M. Rapé,et al.  The Ubiquitin Code , 2012, Annual review of biochemistry.

[27]  Wenyi Wei,et al.  The Fbw7 and betaTRCP E3 ubiquitin ligases and their roles in tumorigenesis. , 2012, Frontiers in bioscience.

[28]  P. Oliver,et al.  The impact of novel retinoids in combination with platinum chemotherapy on ovarian cancer stem cells. , 2012, Gynecologic oncology.

[29]  J Laterra,et al.  Regulation of glioblastoma stem cells by retinoic acid: role for Notch pathway inhibition , 2011, Oncogene.

[30]  A. Klein-Szanto,et al.  Esophageal squamous cell dysplasia and delayed differentiation with deletion of krüppel-like factor 4 in murine esophagus. , 2010, Gastroenterology.

[31]  M. Pagano,et al.  The ubiquitin-specific protease USP47 is a novel β-TRCP interactor regulating cell survival , 2010, Oncogene.

[32]  G. Smyth,et al.  ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays. , 2009, Journal of immunological methods.

[33]  David Komander,et al.  Breaking the chains: structure and function of the deubiquitinases , 2009, Nature Reviews Molecular Cell Biology.

[34]  C. Tzao,et al.  Reduced Axin Protein Expression Is Associated with a Poor Prognosis in Patients with Squamous Cell Carcinoma of Esophagus , 2009, Annals of Surgical Oncology.

[35]  Lu Chen,et al.  Retinoic acid-gated sequence-specific translational control by RARα , 2008, Proceedings of the National Academy of Sciences.

[36]  M. Hung,et al.  Dual regulation of Snail by GSK-3β-mediated phosphorylation in control of epithelial–mesenchymal transition , 2004, Nature Cell Biology.

[37]  K. Guan,et al.  A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF(beta-TRCP). , 2010, Genes & development.